U.S. Central Lab Market Insights by Service, Phase, and End User
According to Shivani Zoting, who specializes in Healthcare Diagnostics, Clinical Research Services, and Life Sciences Markets, with 5+ years of experience in market research and industry analysis. Her research indicates that the U.S. central lab market is set to grow from USD 2.58 billion in 2026 to USD 5.19 billion by 2035, driven by expanding clinical trial activity, precision medicine adoption, and increasing demand for standardized testing services. The study identifies safety testing, genomic and molecular testing, and oncology applications as key growth areas, while the Northeast continues to lead due to its strong life sciences ecosystem. Analysis of the competitive landscape highlights the influence of major participants such as Labcorp, IQVIA, Quest Diagnostics, Thermo Fisher Scientific, Eurofins Scientific, and Medpace, alongside growing investments in advanced diagnostics, biomarker testing, and decentralized clinical trial support.
Last Updated : 18 June 2026
Category: Therapeutic Area
Insight Code: 6920
Format: PDF / PPT / Excel